Lexicon Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Provides Business Update
ET
- ET
THE WOODLANDS, Texas, March 11, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today reported financial results for the three months ended December 31, 2023 and provided an update on key corporate milestones. - “2023 was a pivotal year for Lexicon,” said Lonnel Coats, Lexicon’s chief executive officer.
- Unless otherwise stated, all comparisons are for the fourth quarter and full year of 2023 compared to the fourth quarter and full year of 2022.
- Revenues: Revenues for the fourth quarter and full year of 2023 were $0.7 million and $1.2 million, respectively, primarily from the commercialization of INPEFA.